Bill to set up biotech regulator introduced in LS

Image
Press Trust of India New Delhi
Last Updated : Apr 22 2013 | 5:30 PM IST
A bill to establish a statutory independent regulator for biotech sector covering research, transport, import, manufacture and use of organisms and products of modern biotechnology was introduced in the Lok Sabha today.
The Bill, which has been on the drafting board for years and had run into stiff opposition from green activists, was introduced by Minister for Science and Technology S Jaipal Reddy, who rejected objections raised by CPI(M) member Basudeb Acharia.
As Reddy sought the leave of the Lok Sabha to introduce the Biotechnology Regulatory Authority of India Bill, Acharia objected to it contending that Department of Biotechnology, the promoter of the science, cannot be its regulator.
"Recently, the Standing Committee on Agriculture in its Report on Genetically Modified Foods and Crops, recommended that there should be a non-incumbency Regulatory Authority," said Acharia, who is the chairman of the Standing Committee.
Reddy termed Acharia's objections as untenable and said that the Bill was being done within the legislative competence of Parliament.
The proposed regulator would be a nodal agency of the government to ensure comprehensive safety assessment of organisms and products of modern biotechnology.
The commercialisation of biotechnology products in agriculture and healthcare would be subject to all other laws for the time being in force, the Bill stated.
The biotech regulator would regulate trials preceding the clinical trials in the health sector and the present mechanism for regulating clinical trials would continue, it said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 22 2013 | 5:30 PM IST

Next Story